Literature DB >> 19616385

Processing efficacy in relation to microbial contamination of skin allografts from 723 donors.

E Pianigiani1, F Ierardi, C Cuciti, S Brignali, M Oggioni, M Fimiani.   

Abstract

The Siena Skin Bank, established in 2000, processes skin from more than 130 cadaveric donors per year (about 400,000 cm(2)) and distributes it for transplants to treat burns and other types of skin loss. More than 1,500,000 cm(2) of homologous skin has been transplanted to date. At the Siena Skin Bank we conducted a retrospective study of our data to assess microbial contamination of skin specimens from 723 donors banked in the period 2000-2007. Our aim was to determine factors deleterious for skin quality, to optimize skin banking procedures and to reduce corrective actions. The factors analyzed were: type of donor (multi-organ, multi-tissue, live or cadaver), cause of death, time elapsing between death and procurement, different procurement centres and operator experience. Of the 723 donors considered, 26.55% (192/723) were positive for microbes, 22.68% (164) for bacteria and 5.39% (39) for mycetes. Of these 192 positives, 82 (42.70%) required corrective actions. The data obtained showed that the only variables significantly affecting microbial contamination of tissue were type of donor (live or cadaver) and type of processing (cryo- or glycerol preservation). Copyright 2009 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19616385     DOI: 10.1016/j.burns.2009.04.020

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  8 in total

1.  Biofilm formation and antibiotic susceptibility of Staphylococcus and Bacillus species isolated from human allogeneic skin.

Authors:  Micaela do Canto Canabarro; Karine Lena Meneghetti; Mercedes Passos Geimba; Gertrudes Corção
Journal:  Braz J Microbiol       Date:  2021-11-04       Impact factor: 2.476

2.  Skin donations after suicide by acute poisoning.

Authors:  L Amoroso; A Fratini; R Baronti; F Ierardi; M L Migliaccio; M Di Schiena; P Rubegni; E Pianigiani
Journal:  Cell Tissue Bank       Date:  2022-08-30       Impact factor: 1.752

3.  Deceased donor skin allograft banking: Response and utilization.

Authors:  Madhuri A Gore; Anuradha S De
Journal:  Indian J Plast Surg       Date:  2010-09

4.  Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi.

Authors:  Gilbert Verbeken; Gunther Verween; Daniel De Vos; Bruno Pascual; Peter De Corte; Cornelia Richters; Arlette De Coninck; Diane Roseeuw; Nadine Ectors; Thomas Rose; Serge Jennes; Jean-Paul Pirnay
Journal:  Cell Tissue Bank       Date:  2011-03-01       Impact factor: 1.522

5.  Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures.

Authors:  Jean-Paul Pirnay; Gunther Verween; Bruno Pascual; Gilbert Verbeken; Peter De Corte; Thomas Rose; Serge Jennes; Alain Vanderkelen; Miriam Marichal; Walter Heuninckx; Daniel De Vos
Journal:  Cell Tissue Bank       Date:  2011-04-21       Impact factor: 1.522

6.  Microbial contamination and tissue procurement location: A conventional operating room is not mandatory. An observational study.

Authors:  Benjamin Louart; Claire Charles; Tri-Long Nguyen; Nicolas Builles; Claire Roger; Jean-Yves Lefrant; Florence Vachiery-Lahaye; John De Vos; Guilhem Couderc; Laurent Muller
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

Review 7.  Disinfection of human skin allografts in tissue banking: a systematic review report.

Authors:  C Johnston; J Callum; J Mohr; A Duong; A Garibaldi; N Simunovic; O R Ayeni
Journal:  Cell Tissue Bank       Date:  2016-08-13       Impact factor: 1.522

8.  Bacterial contamination of human skin allografts and antimicrobial resistance: a skin bank problem.

Authors:  Karine Lena Meneghetti; Micaela do Canto Canabarro; Letícia Muner Otton; Thaís Dos Santos Hain; Mercedes Passos Geimba; Gertrudes Corção
Journal:  BMC Microbiol       Date:  2018-09-24       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.